Evidence map›Paper›PMID 30474069›Full record

ReviewJournal of the Endocrine Society2018

Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults.

Yogish C Kudva, Andrew J Ahmann, Richard M Bergenstal, James R Gavin, Davida F Kruger, L Kurt Midyett, Eden Miller, Dennis R Harris

Open access · goldAbstract readReview
In one paragraph

Review in Journal of the Endocrine Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Continuous Glucose Monitoring and Physical Activity.International journal of environmental research and public health · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 1 country.

Yogish C KudvaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-0285-6622
Andrew J AhmannDivision of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health and Science University, Portland, Oregon.ORCID 0000-0002-4544-5404
Richard M BergenstalInternational Diabetes Center, Park Nicollet Health Services, Minneapolis, Minnesota.ORCID 0000-0002-9050-5584
James R GavinEmory University School of Medicine, Atlanta, Georgia.ORCID 0000-0003-4901-8781
Davida F KrugerDivision of Endocrinology, Diabetes, and Bone and Mineral Disorders, Henry Ford Health System, Detroit, Michigan.ORCID 0000-0002-3188-8132
L Kurt MidyettSt. Luke's Hospital, Kansas City, Missouri.
Eden MillerHigh Lakes Health Care, St. Charles Hospital, Bend, Oregon.
Dennis R HarrisEndocrine Society, Washington, District of Columbia.ORCID 0000-0002-8262-5818
Emory University · USEndocrine Society · USHenry Ford Health System · USMayo Clinic · USOregon Health & Science University · USPark Nicollet Health Services · USSt. Charles Hospital · USSt. Luke's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of personal continuous glucose monitoring (CGM) has expanded dramatically among individuals with diabetes. CGM systems provide retrospective data, as well as the current glucose value and trend arrow data, which indicate the direction and velocity of changing glucose. In 2017, Aleppo and colleagues developed a simplified approach for adults with diabetes to safely adjust rapid-acting insulin doses using trend arrow information in the Dexcom G5 CGM system. Since then, the FreeStyle Libre and FreeStyle Libre 14-day CGM systems have become available in the United States; however, guidance on using trend arrow data that take the unique features of these systems into consideration is lacking. Specifically, the FreeStyle Libre systems do not have automatic alarms, which impact how the system and trend arrow data are used. The Endocrine Society convened an expert panel to address this gap and develop an approach to adjusting rapid-acting insulin doses for adults using trend arrows in the FreeStyle Libre systems. We based our approach on previous work and expanded upon engagement and scanning recommendations, and we incorporated pre-exercise planning specific to these systems. Our approach provides insulin dose adjustments as discrete insulin units based on an individual's insulin sensitivity and directionality of the trend arrow. We focus on the needs of patients treated with multiple daily injections because these individuals currently make up a greater proportion of individuals on intensive insulin therapy. Our recommendations are intended to provide a safe, practical approach to using trend arrows in the FreeStyle Libre systems.

Indexed as

continuous glucose monitoringdiabetesdiabetes technologyflash glucose monitoringscanningtrend arrows

Identifiers

PMID30474069
PMCPMC6243139
OpenAlexW2900500392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.